Patents: obviousness in relation to patent for dosage regime

http://www.twobirds.com/en/patenthub/shared/articles/2019/global/patents-obviousness-in-relation-to-patent-for-dosage-regime

The Supreme Court has confirmed that a patent for a dosage regime of a drug used to treat erectile dysfunction (ED) was obvious over the prior art.

08 May 2019

Patents: possible defence to infringement by equivalence

http://www.twobirds.com/en/patenthub/shared/articles/2019/global/patents-possible-defence-to-infringement-by-equivalence

The Intellectual Property Enterprise Court (IPEC) has held that a patent was invalid but also considered a possible defence to infringement by equivalence.

03 April 2019

UK Court grants SEP injunction: TQ Delta v ZyXEL

http://www.twobirds.com/en/patenthub/shared/articles/2019/uk/uk-court-grants-sep-injunction-tq-delta-v-zyxel

UK Court shows it is prepared to manage SEP cases efficiently and grant injunctions on SEPs when warranted.

02 April 2019

Supreme Court holds Dosage Regime Patent Obvious

http://www.twobirds.com/en/patenthub/shared/articles/2019/global/supreme-court-holds-dosage-regime-patent-obvious

Today in Actavis v ICOS the Supreme Court unanimously ruled that the ICOS patent for a Tadalafil dosing regime was invalid. Lord Hodge gave the only judgment, with Lady Hale, Lord Kerr, Lord Sumption and Lord Briggs in agreement. The case attracted ...

27 March 2019

Patents: infringement by equivalence

http://www.twobirds.com/en/patenthub/shared/articles/2019/uk/patents-infringement-by-equivalence

The High Court has held that a patent was invalid as anticipated by a prior disclosure by the patent owner and obvious over an item of cited prior art.

05 March 2019